Yes — memory loss, confusion, or trouble thinking after starting or changing a medicine can be a drug effect, and a prescriber review can identify the cause. A prescriber review is a focused appointment to check every drug and supplement for risks, interactions, and safer options. Bring a clear timeline of what changed, when symptoms started, and every product taken. That record helps the clinician decide whether to adjust a dose, stop a drug, or look for another cause.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which medicines are linked to memory problems?
- Do these changes reverse after stopping?
- Which drugs need extra caution in dementia?
- What should you bring to the review?
Which medicines are linked to memory problems?
The National Institute on Aging states that some medicines and combinations can cause confusion, memory loss, hallucinations, and delusions in older adults, as described in the NIA cognitive health page. Risk rises when several cognition-impairing drugs are used together. Strong anticholinergics are a leading concern. Researchers found continuous use of strong anticholinergics for as few as 60 days caused cognitive impairment in 3,690 older adults.
Use of multiple weak anticholinergics for 90 days had a similar effect. Statins have also been linked to memory complaints. The FDA required statin labels to warn about reported forgetfulness and confusion, as summarized by the National Lipid Association in the FDA label-change summary. Onset ranged from one day to years after starting and occurred across ages.
Do these changes reverse after stopping?
The outlook depends on the drug, dose, duration, and person. For statins, a 2025 NIH review describes cognitive effects as rare, non-serious, and reversible within about three weeks of stopping, without evidence of progressive dementia. Longer or repeated anticholinergic exposure carries greater concern.
A neuroimaging study in cognitively normal older adults linked anticholinergic use to more brain atrophy, lower metabolism, and poorer memory and executive function. That pattern means early review matters. Do not stop a prescribed heart, brain, sleep, mood, or seizure medicine on your own to test whether memory improves.
Which drugs need extra caution in dementia?
The American Geriatrics Society Beers Criteria advise avoiding anticholinergics, benzodiazepines, nonbenzodiazepine hypnotics, and antipsychotics in older adults with dementia or cognitive impairment. The reason is that these groups can worsen cognition and confusion. Benzodiazepines, medicines often prescribed for anxiety or sleep, carry added dependence risks.
In September 2020, the FDA required a boxed warning for abuse, addiction, physical dependence, and withdrawal. Dependence can develop within days to weeks. Abrupt stopping can cause harm, so any taper needs clinician supervision.
What should you bring to the review?
Pack every prescription, over-the-counter product, and supplement in its original container. Add a written list with name, dose, frequency, reason for use, start and change dates, symptom timeline, and top questions, following the PinnacleCare medication-review checklist.
Use this short checklist before the visit: Bring a family member or caregiver when possible. A second person can confirm the timeline and record new instructions.
- List each product, dose, time of day, prescriber, and purpose.
- Mark exact start, stop, dose-change, and symptom dates.
- Note sleep, falls, confusion episodes, hallucinations, and daily-function changes.
- Rank your top three questions, such as which drug is most suspect and what safer options exist.





